新規登録 | ログイン | FAQ      [?] 

タグ: as [227 articles]

Recent papers classified by the tag as.
  • Depicting Women as Sex Objects in Television Advertising: Effects on Body Dissatisfaction
    Pers Soc Psychol Bull, Vol. 25, No. 8. (1 August 1999), pp. 1049-1058.
    by Howard Lavine, Donna Sweeney, Stephen H Wagner
    posted to as objects sex women by zblh17 on 2008-03-18 19:33:45 as ***
  • Description logics of minimal knowledge and negation as failure
    ACM Trans. Comput. Logic, Vol. 3, No. 2. (April 2002), pp. 177-225.
    by Francesco M Donini, Daniele Nardi, Riccardo Rosati
    posted to as description failure knowledge logic minimal modal negation by yarden on 2005-03-17 04:19:12 as ****
  • The contemporary museum and leisure: recreation as a museum function
    Museum Management and Curatorship, Vol. 19, No. 3. (September 2001), pp. 297-308.
    by A Stephen
    posted to as leisure museums by yachunlee on 2005-10-15 16:38:27 as **** along with 1 person and 1 group rjurban GSLIS-CSCW
  • Applying Reassurance Policing: Is it Business as Usual?
    Policing and Society, Vol. 16, No. 2. (June 2006), pp. 146-163.
    by Herrington, Victoria, Millie, Andrew
    posted to as business policing society usual by xxxxxxxxxxx on 2008-02-24 12:31:37 as ***
  • Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 2. (February 2007), pp. 251-258.
    by Armstrong, P Edward, Skrepnek, H Grant, Haim Erder,
    posted to as depression by worx11 on 2007-08-22 17:50:54 as ** along with 1 group XROWXR
  • Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan
    Journal of Clinical Pharmacy & Therapeutics, Vol. 32, No. 4. (August 2007), pp. 353-363.
    by Wu, -S, Chen, -C, Lu, -B
    posted to as depression by worx11 on 2007-08-22 17:45:43 as ** along with 1 group XROWXR
  • Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Int Clin Psychopharmacol, Vol. 22, No. 2. (March 2007), pp. 107-115.
    by B Fantino, N Moore, H Verdoux, JP Auray
    posted to as depression by worx11 on 2007-10-18 17:22:13 as ** along with 1 group XROWXR
  • Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.
    Arch Gen Psychiatry, Vol. 62, No. 8. (August 2005), pp. 868-875.
    by DA Revicki, J Siddique, L Frank, JY Chung, BL Green, J Krupnick, M Prasad, J Miranda
    posted to as depression by worx11 on 2007-08-22 17:12:39 as ** along with 1 group XROWXR
  • Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
    Pharmacoeconomics, Vol. 23, No. 2. (2005), pp. 155-167.
    by JL Fernandez, S Montgomery, C Francois
    posted to as depression by worx11 on 2007-08-22 17:12:14 as ** along with 1 group XROWXR
  • Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.
    Eur J Health Econ, Vol. 6, No. 4. (December 2005), pp. 317-321.
    by W Kulp, JM von der Schulenburg, W Greiner
    posted to as depression by worx11 on 2007-08-22 17:08:41 as ** along with 1 group XROWXR
  • A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
    Clinical Therapeutics, Vol. 27, No. 1. (January 2005), pp. 111-124.
    by Koen Demyttenaere, Michiel E Hemels, Joumana Hudry, Lieven Annemans
    posted to as depression by worx11 on 2007-08-22 17:05:44 as ** along with 1 group XROWXR
  • Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Am J Cardiol, Vol. 97, No. 2A. (16 January 2006)
    by S Mora, PM Ridker
    posted to as cr_supplement statin by worx11 on 2007-07-30 16:35:21 as **** along with 1 group XROWXR
  • A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom
    Clinical Therapeutics, Vol. 27, No. 4. (April 2005), pp. 486-496.
    by Alan G Wade, Idris Toumi, Michiel E Hemels
    posted to as depression by worx11 on 2007-08-22 16:54:52 as ** along with 1 group XROWXR
  • Disease-specific health education for COPD: a systematic review of changes in health outcomes.
    Health Educ Res, Vol. 22, No. 5. (October 2007), pp. 703-717.
    by F Blackstock, K Webster
    posted to as copd by worx11 on 2007-09-16 14:24:32 as ** along with 1 group XROWXR
  • Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective.
    Value Health, Vol. 7, No. 5. (t 2004), pp. 535-543.
    by HS Javitz, GE Swan, SM Zbikowski, SJ Curry, TA McAfee, D Decker, R Patterson, LM Jack
    posted to as smoking_cessation by worx11 on 2007-09-16 14:15:51 as ** along with 1 group XROWXR
  • Workplace interventions for smoking cessation.
    Cochrane Database Syst Rev, No. 2. (2005)
    by M Moher, K Hey, T Lancaster
    posted to as smoking_cessation by worx11 on 2007-09-16 14:07:20 as ** along with 1 group XROWXR
  • Statins and Mortality Among Elderly Patients Hospitalized With Heart Failure
    Circulation, Vol. 113, No. 8. (28 February 2006), pp. 1086-1092.
    by Joanne M Foody, Rahman Shah, Deron Galusha, Frederick A Masoudi, Edward P Havranek, Harlan M Krumholz
    posted to as cr_supplement statin by worx11 on 2007-07-30 15:44:59 as ***** along with 1 group XROWXR
  • Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.
    J Card Fail, Vol. 12, No. 8. (October 2006), pp. 664-674.
    by KK Khush, DD Waters
    posted to as cr_supplement statin by worx11 on 2007-07-30 15:39:48 as **** along with 1 group XROWXR
  • The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk
    Expert Review of Cardiovascular Therapy, Vol. 5, No. 2. (March 2007), pp. 177-193.
    by Schuster, Herbert
    posted to as cr_supplement statin by worx11 on 2007-07-30 15:38:14 as **** along with 1 group XROWXR
  • A budget-impact and cost-effectiveness model for second-line treatment of major depression.
    J Manag Care Pharm, Vol. 13, No. 6. (g 2007), pp. 8-18.
    by DC Malone
    posted to as depression by worx11 on 2007-08-22 16:07:51 as ** along with 1 group XROWXR
  • Evidence of cost-effective treatments for depression: a systematic review.
    J Affect Disord, Vol. 84, No. 1. (January 2005), pp. 1-13.
    by B Barrett, S Byford, M Knapp
    posted to as depression by worx11 on 2007-08-22 16:07:06 as ** along with 1 group XROWXR
  • Discontinuation symptoms in depression and anxiety disorders.
    Int J Neuropsychopharmacol (19 December 2005), pp. 1-12.
    by David S S Baldwin, Stuart A A Montgomery, Rico Nil, Malcolm Lader
    posted to as depression by worx11 on 2007-08-21 20:25:18 as ** along with 1 person and 1 group torfis XROWXR
  • Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents.
    Biol Psychiatry (21 June 2007)
    by George I I Papakostas, Michael E E Thase, Maurizio Fava, J Craig Nelson, Richard C C Shelton
    posted to as depression by worx11 on 2007-08-21 20:20:58 as ** along with 1 group XROWXR
  • Systematic review: smoking cessation intervention strategies for adults and adults in special populations.
    Ann Intern Med, Vol. 145, No. 11. (5 December 2006), pp. 845-856.
    by L Ranney, C Melvin, L Lux, E McClain, KN Lohr
    posted to as smoking_cessation by worx11 on 2007-09-16 20:49:32 as ** along with 1 person and 1 group jyuh XROWXR
  • Economic Evaluations of Smoking Cessation and Relapse Prevention Programs for Pregnant Women: A Systematic Review.
    Value Health (13 September 2007)
    by Jennifer Prah P Ruger, Karen M M Emmons
    posted to as smoking_cessation by worx11 on 2007-09-16 20:48:10 as ** along with 1 group XROWXR
  • Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.
    Respir Med, Vol. 101, No. 3. (March 2007), pp. 371-377.
    by R Wood-Baker, J Walters, EH Walters
    posted to as copd by worx11 on 2007-09-16 20:47:24 as ** along with 1 group XROWXR
  • Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    COPD, Vol. 4, No. 2. (June 2007), pp. 135-142.
    by WM Vollmer, D Peters, B Crane, C Kelleher, AS Buist
    posted to as copd by worx11 on 2007-09-16 20:46:08 as ** along with 1 group XROWXR
  • Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Clin Ther, Vol. 29, No. 6. (June 2007), pp. 1203-1213.
    by KL Rascati, M Akazawa, M Johnsrud, RH Stanford, CM Blanchette
    posted to as copd by worx11 on 2007-09-16 20:45:45 as ** along with 1 group XROWXR
  • The Relationship Between Exercise Tolerance and Other Outcomes in COPD.
    COPD, Vol. 4, No. 3. (September 2007), pp. 205-216.
    by MJ Berry
    posted to as copd by worx11 on 2007-09-16 20:45:08 as ** along with 1 group XROWXR
  • Update on the pharmacologic therapy for chronic obstructive pulmonary disease.
    Clin Chest Med, Vol. 28, No. 3. (September 2007), pp. 589-607.
    by NA Hanania, A Sharafkhaneh
    posted to as copd by worx11 on 2007-09-16 20:44:45 as ** along with 1 group XROWXR
  • Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation
    International Journal of Clinical Practice, Vol. 61, No. 4. (April 2007), pp. 702-710.
    by Llorca, , Fernandez, -L
    posted to as depression by worx11 on 2007-08-21 20:04:59 as ** along with 1 group XROWXR
  • Self-management strategies in chronic obstructive pulmonary disease.
    Clin Chest Med, Vol. 28, No. 3. (September 2007), pp. 617-628.
    by J Bourbeau, D Nault
    posted to as copd by worx11 on 2007-09-16 20:44:16 as ** along with 1 group XROWXR
  • Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease.
    Respir Med (3 September 2007)
    by A Niesink, J C A C Trappenburg, G H H de Weert-van Oene, J W J W Lammers, T J M J Verheij, A J P J Schrijvers
    posted to as copd quality by worx11 on 2007-09-16 20:43:21 as ** along with 1 group XROWXR
  • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary.
    Am J Respir Crit Care Med, Vol. 176, No. 6. (15 September 2007), pp. 532-555.
    by KF Rabe, S Hurd, A Anzueto, PJ Barnes, SA Buist, P Calverley, Y Fukuchi, C Jenkins, R Rodriguez-Roisin, C van Weel, J Zielinski
    posted to as copd by worx11 on 2007-09-16 20:41:22 as ** along with 1 group XROWXR
  • Evidence based review of escitalopram in treating major depressive disorder in primary care.
    Int Clin Psychopharmacol, Vol. 19, No. 5. (September 2004), pp. 305-310.
    by TR Einarson
    posted to as depression by worx11 on 2007-08-21 20:00:43 as ** along with 1 group XROWXR
  • COPD Guidelines: The Important Thing Is Not to Stop Questioning.
    Am J Respir Crit Care Med, Vol. 176, No. 6. (15 September 2007), pp. 527-528.
    by LM Fabbri, P Boschetto, CE Mapp
    posted to as copd by worx11 on 2007-09-16 20:39:58 as ** along with 1 group XROWXR
  • Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
    Ann Intern Med, Vol. 143, No. 6. (20 September 2005), pp. 415-426.
    by RA Hansen, G Gartlehner, KN Lohr, BN Gaynes, TS Carey
    posted to ahrq as depression by worx11 on 2007-08-21 19:56:20 as ** along with 1 group XROWXR
  • Impacts of a smoking cessation benefit among employed populations.
    J Occup Environ Med, Vol. 49, No. 1. (January 2007), pp. 11-21.
    by MT Halpern, R Dirani, JK Schmier
    posted to as smoking_cessation by worx11 on 2007-09-16 20:32:09 as ** along with 1 group XROWXR
  • Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 6. (June 2007), pp. 1303-1318.
    by Pigott, A Teresa, Prakash, Apurva, Arnold, M Lesley, Aaronson, T Scott, Mallinckrodt, H Craig, Wohlreich, M Madelaine
    posted to ahrq as depression by worx11 on 2007-08-21 19:49:16 as ** along with 1 group XROWXR
  • Recruiting pregnant smokers into a clinical trial: using a network-model managed care organization versus community-based practices.
    Prev Med, Vol. 44, No. 3. (March 2007), pp. 223-229.
    by ER Park, VP Quinn, Y Chang, S Regan, B Loudin, S Cummins, K Perry, NA Rigotti
    posted to as smoking_cessation by worx11 on 2007-09-16 20:27:27 as ** along with 1 group XROWXR
  • An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
    J Occup Environ Med, Vol. 49, No. 4. (April 2007), pp. 453-460.
    by KC Jackson, R Nahoopii, Q Said, R Dirani, D Brixner
    posted to as cost_benefit smoking_cessation by worx11 on 2007-09-16 20:25:16 as ** along with 1 group XROWXR
  • A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 7. (July 2007), pp. 1605-1614.
    by Wade, , Gembert, , Florea,
    posted to ahrq as depression by worx11 on 2007-08-21 19:44:13 as ** along with 1 group XROWXR
  • Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Clin Drug Investig, Vol. 27, No. 7. (2007), pp. 481-492.
    by A Khan, A Bose, GS Alexopoulos, C Gommoll, D Li, C Gandhi
    posted to ahrq as depression by worx11 on 2007-08-21 19:37:12 as ** along with 1 group XROWXR
  • Effectiveness of an Internet-Based Worksite Smoking Cessation Intervention at 12 Months.
    J Occup Environ Med, Vol. 49, No. 8. (August 2007), pp. 821-828.
    by Amanda L Graham, Nathan K Cobb, Linda Raymond, Stewart Sill, Joyce Young
    posted to as smoking_cessation by worx11 on 2007-09-16 20:17:24 as ** along with 1 group XROWXR
  • Cost-Effectiveness of Motivational Interviewing for Smoking Cessation and Relapse Prevention among Low-Income Pregnant Women: A Randomized Controlled Trial.
    Value Health (13 September 2007)
    by Jennifer Prah P Ruger, Milton C C Weinstein, S Katherine K Hammond, Margaret H H Kearney, Karen M M Emmons
    posted to as smoking_cessation by worx11 on 2007-09-16 20:15:15 as ** along with 1 group XROWXR
  • Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management.
    Arch Intern Med, Vol. 167, No. 6. (26 March 2007), pp. 551-561.
    by SG Adams, PK Smith, PF Allan, A Anzueto, JA Pugh, JE Cornell
    posted to as copd by worx11 on 2007-09-16 20:03:42 as ** along with 1 group XROWXR
  • SSRIs versus other antidepressants for depressive disorder.
    Cochrane Database Syst Rev, No. 2. (2000)
    by JR Geddes, N Freemantle, J Mason, MP Eccles, J Boynton
    posted to as depression by worx11 on 2007-10-18 13:30:13 as ** along with 1 group XROWXR
  • WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Cochrane Database Syst Rev, No. 3. (2007)
    by C Barbui, M Hotopf, N Freemantle, J Boynton, R Churchill, MP Eccles, JR Geddes, R Hardy, G Lewis, JM Mason
    posted to as depression by worx11 on 2007-10-18 13:29:50 as ** along with 1 group XROWXR
  • WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Cochrane Database Syst Rev, No. 3. (2007)
    by JR Geddes, N Freemantle, J Mason, MP Eccles, J Boynton
    posted to as depression by worx11 on 2007-10-18 13:29:29 as ** along with 1 group XROWXR
  • [Review of double-blind studies comparing SSRI and SNRI]
    Seishin Shinkeigaku Zasshi, Vol. 106, No. 10. (2004), pp. 1203-1217.
    by E Suzuki, S Maruta
    posted to as depression by worx11 on 2007-10-18 13:29:01 as ** along with 1 group XROWXR
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/as

    Result page: 1 2 3 4 5 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.